Evidence map›Paper›PMID 38757285›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024.

Beatriz Valcarcel Salamanca, Pascale Renée Cyr, Yngvild Emblem Bentdal, Sara Viksmoen Watle, Astrid Louise Wester, Åse Marie Wikman Strand, Håkon Bøås

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Observational
  2. Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Molecular Characterization ofMicroorganisms · 2025
    Article
  17. Observational
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Beatriz Valcarcel SalamancaDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Pascale Renée CyrDepartment of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
Yngvild Emblem BentdalDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Sara Viksmoen WatleDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Astrid Louise WesterDepartment of Bacteriology, Norwegian Institute of Public Health, Oslo, Norway.
Åse Marie Wikman StrandDepartment of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
Håkon BøåsDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the end of 2022 and most notably during the first half of 2023, the number of invasive group A streptococcus (iGAS) notifications increased in Norway, largely affecting children younger than 10 years, as observed in several other countries. Following this atypical season, a new surge in the number of iGAS notifications began in December 2023 and peaked between January and February 2024, now particularly affecting both children younger than 10 years and older adults (70 years and above).

Indexed as

Streptococcal InfectionsStreptococcus pyogenesAdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolDisease NotificationFemaleHumansIncidenceInfantMaleMiddle AgedGroup A StreptococcusiGASinvasiveoutbreakStreptococcus pyogenes

Identifiers

PMID38757285
PMCPMC11100296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.